Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hereditary ovarian cancer in women with African ancestry: a scoping review. | Fam Cancer | 2026 | 41619087 | PubTator, text mining | PubMed |
| A novel dual histone mark reader ZCWPW2 regulates meiotic recombination through lactylation and transcriptional regulation in humans and mice. | Nucleic Acids Res | 2026 | 41574437 | PubTator, text mining | PubMed |
Hereditary Risk Assessment of Cancer Using Clinical History in Patients Diagnosed with Breast or Ovarian Cancer Receiving Treatment at Tertiary Care Hospital in Western Rajasthan - A Cross-sectional Study. | Ann Afr Med | 2026 | 41568657 | PubTator, text mining | PubMed |
| Tyrer-Cuzick Lifetime Risk Is Not Associated With Non-BRCA1/2 Pathogenic Variants for Breast Carcinoma. | Breast J | 2026 | 41568159 | PubTator, text mining | PubMed |
| Hereditary ovarian cancer. | Discov Oncol | 2026 | 41538105 | PubTator, text mining | PubMed |
| Molecular mechanisms of CYP-13 function in C. elegans: insights into conserved P450 pathways. | Arch Toxicol | 2026 | 41535584 | PubTator, text mining | PubMed |
| Putative breast cancer risk variants from populations of South Asian ancestry are under-represented in public variant classification databases. | Breast Cancer Res | 2026 | 41530809 | PubTator, text mining | PubMed |
| Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients. | BMC Med | 2026 | 41530754 | PubTator, text mining | PubMed |
| Genetic tumor syndromes in female cancer: insights into inherited cancer predisposition and clinical implications. | Arch Gynecol Obstet | 2026 | 41528496 | PubTator, text mining | PubMed |
| [Characteristics of uterine leiomyosarcoma: a clinicopathological and molecular genetic analysis of twenty-four cases]. | Zhonghua Bing Li Xue Za Zhi | 2026 | 41490636 | PubTator, text mining | PubMed |
| Functional assessment of protein variants in structured domains by fluorescence cross-correlation spectroscopy. | Sci Rep | 2026 | 41484234 | PubTator, text mining | PubMed |
| Distinct mechanisms of recognition of phosphorylated RNAPII C-terminal domain by BRCT repeats of the BRCA1-BARD1 complex. | J Biol Chem | 2026 | 41354346 | PubTator, text mining | PubMed |
| Hpv-driven rewiring of the tumor immune microenvironment through single-cell profiling informs prognosis and therapy in HNSCC. | Oral Oncol | 2026 | 41314067 | PubTator, text mining | PubMed |
| Germline Mutation Analysis and Real-World Impact in a Selected Cohort of Patients with Non-Small Cell Lung Cancer: INHERITY LC Study. | Clin Lung Cancer | 2026 | 41290502 | PubTator, text mining | PubMed |
| Eligibility for bilateral prophylactic mastectomy: An expert opinion study in the Netherlands. | Breast | 2026 | 41274190 | PubTator, text mining | PubMed |
| The NSUN5 gene rs1880948 A>G polymorphism and neuroblastoma risk in Chinese children. | Front Oncol | 2025 | 41536427 | PubTator, text mining | PubMed |
| Genomic Profiling of Highly Aggressive Musculoskeletal Sarcomas Identifies Potential Therapeutic Targets: A Single-Center Experience. | Cancers (Basel) | 2025 | 41514647 | PubTator, text mining | PubMed |
| Integrative sWGS: A New Paradigm for HRD Detection in Ovarian Cancer. | Int J Mol Sci | 2025 | 41465396 | PubTator, text mining | PubMed |
| Case Report: SMARCA4-deficient NSCLC with brain metastasis harboring co-mutations in chromatin remodeling and DNA damage repair pathways. | Front Oncol | 2025 | 41395620 | PubTator, text mining | PubMed |
| Characterization of a Genetic Variant in BARD1 in Subjects Undergoing Germline Testing for Hereditary Tumors. | Biomedicines | 2025 | 41301857 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=5